Published in Clin Infect Dis on September 16, 2014
Severe hemolysis as a potential contributing factor in the pathophysiology of cerebral malaria. Clin Infect Dis (2014) 1.06
The endothelial protein C receptor rs867186-GG genotype is associated with increased soluble EPCR and could mediate protection against severe malaria. Sci Rep (2016) 0.75
Reply to Eisenhut. Clin Infect Dis (2014) 0.75
Exploring experimental cerebral malaria pathogenesis through the characterisation of host-derived plasma microparticle protein content. Sci Rep (2016) 0.75
Erythropoietin Levels Increase during Cerebral Malaria and Correlate with Heme, Interleukin-10 and Tumor Necrosis Factor-Alpha in India. PLoS One (2016) 0.75
Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke (2009) 5.28
Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg (2001) 4.83
Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med (2005) 4.65
Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science (2004) 4.09
Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med (2002) 3.87
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A (2001) 3.80
Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics (2007) 2.47
Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics (2008) 2.45
Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience (1997) 2.25
Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem (1993) 2.25
Recombinant human erythropoietin prevents the death of mice during cerebral malaria. J Infect Dis (2006) 2.06
Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res (2002) 2.04
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res (2010) 1.98
Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci (1996) 1.91
Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood (2006) 1.83
High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Proc Natl Acad Sci U S A (2008) 1.54
Abnormal iron distribution in infants of diabetic mothers: spectrum and maternal antecedents. J Pediatr (1990) 1.51
Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood (2000) 1.45
Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria. Malar J (2008) 1.25
Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev Anti Infect Ther (2010) 1.20
Modulation of the course and outcome of blood-stage malaria by erythropoietin-induced reticulocytosis. J Infect Dis (2004) 1.17
Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding. Thromb Haemost (2009) 1.16
Increased erythropoietin production in children with severe malarial anemia. Am J Trop Med Hyg (1995) 1.13
Serum erythropoietin levels during infancy: associations with erythropoiesis. J Pediatr (1996) 1.10
Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo. Pediatrics (2014) 1.04
A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci U S A (2005) 1.03
Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali. Malar J (2009) 1.01
Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and treatment effects. J Appl Physiol (1985) (1996) 1.00
Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease. Clin J Am Soc Nephrol (2011) 0.96
High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO). Thromb Haemost (2008) 0.95
Neuronal damage after moderate hypoxia and erythropoietin. Neurobiol Dis (2005) 0.93
Plasma factor(s) influencing red cell production. Nature (1956) 0.90
Erythropoietin and its receptors in the brainstem of adults with fatal falciparum malaria. Malar J (2009) 0.87
Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis. Pediatr Nephrol (1997) 0.82
Erythropoietin levels are not independently associated with malaria-attributable severe disease in Mozambican children. PLoS One (2011) 0.82
Reply to Eisenhut. Clin Infect Dis (2014) 0.75